Neuraxpharm Arzneimittel Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Neuraxpharm Arzneimittel and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 174 Neuraxpharm Arzneimittel employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Neuraxpharm Arzneimittel has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2017, Microsoft 365 for Collaboration in 2017, Cisco Secure Email (formerly Email Security Appliance) for Secure Email Gateways (SEGs) in 2022 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Neuraxpharm Arzneimittel is running and its propensity to invest more and deepen its relationship with Microsoft , Amazon Web Services (AWS) , Mittwald or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Neuraxpharm Arzneimittel revenues, which have grown to $119.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Neuraxpharm Arzneimittel intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.